Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Kivu Bioscience Inc.
AstraZeneca
MacroGenics
Boundless Bio, Inc.
National Institutes of Health Clinical Center (CC)
Novelty Nobility, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
Hutchmed
Stanford University
Sarcoma Oncology Research Center, LLC
Cybrexa Therapeutics
Cyteir Therapeutics, Inc.
Xencor, Inc.
TransThera Sciences (Nanjing), Inc.
Memorial Sloan Kettering Cancer Center
Sierra Oncology LLC - a GSK company
Translational Research in Oncology
Shanghai Yunying Medical Technology
Eastern Cooperative Oncology Group
Novartis
SpeciCare
Celgene
Cambridge University Hospitals NHS Foundation Trust
Swiss Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pfizer
Western Regional Medical Center
Merrimack Pharmaceuticals
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Imunon
Dana-Farber Cancer Institute
Novartis
Virginia Commonwealth University
Memorial Sloan Kettering Cancer Center
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
Novartis
Jonsson Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Astellas Pharma Inc
NYU Langone Health
Case Comprehensive Cancer Center